Jaguar Health, Inc. JAGX
0.23 USD -0.10 (-30.58%)
Regular-session close
0.22 -0.01 -2.64%
After hours · Nov 20, 7:58 PM ET
0.22 Day range 0.3278
0.22 52-week range 981.75
- YTD
- -99.95%
- 1 year
- -99.97%
JAGX revenue history
Revenue is income from the company’s ordinary business activities.
11,511,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 11,511,000 | -178,000 | -1.52% |
| FY 2024 | 2024-12-31 | 11,689,000 | 1,928,000 | 19.75% |
| FY 2023 | 2023-12-31 | 9,761,000 | -2,195,000 | -18.36% |
| FY 2022 | 2022-12-31 | 11,956,000 | 7,621,000 | 175.80% |
| FY 2021 | 2021-12-31 | 4,335,000 | -5,050,000 | -53.81% |
| FY 2020 | 2020-12-31 | 9,385,000 | 3,610,000 | 62.51% |
| FY 2019 | 2019-12-31 | 5,775,000 | 1,358,855 | 30.77% |
| FY 2018 | 2018-12-31 | 4,416,145 | 54,959 | 1.26% |
| FY 2017 | 2017-12-31 | 4,361,186 | 4,219,663 | 2981.61% |
| FY 2016 | 2016-12-31 | 141,523 | -116,858 | -45.23% |
| FY 2015 | 2015-12-31 | 258,381 | 258,381 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-09-19T06:00:49.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
